Signature molecular changes in the skeletal muscle of hindlimb unloaded mice

Hind-limb unloaded (HU) mouse is a well-recognized model of muscle atrophy; however, the molecular changes in the skeletal muscle during unloading are poorly characterized. We have used Raman spectroscopy to evaluate the structure and behavior of signature molecules involved in regulating muscle str...

Full description

Saved in:
Bibliographic Details
Published in:Biochemistry and biophysics reports Vol. 25; p. 100930
Main Authors: Azeem, Muhammad, Qaisar, Rizwan, Karim, Asima, Ranade, Anu, Elmoselhi, Adel
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01-03-2021
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hind-limb unloaded (HU) mouse is a well-recognized model of muscle atrophy; however, the molecular changes in the skeletal muscle during unloading are poorly characterized. We have used Raman spectroscopy to evaluate the structure and behavior of signature molecules involved in regulating muscle structural and functional health. The Raman spectroscopic analysis of gastrocnemius muscles was compared between 16-18 weeks old HU c57Bl/6J mice and ground-based controls. The spectra showed that the signals for asparagine and glutamine were reduced in HU mice, possibly indicating increased catabolism. The peaks for hydroxyproline and proline were split, pointing towards molecular breakdown and reduced tendon repair. We also report a consistently increased intensity in> 1300 cm-1 range in the Raman spectra along with a shift towards higher frequencies in the HU mice, indicating activation of sarcoplasmic reticulum (SR) stress during HU. •A thorough understanding of molecular changes underlying muscle detriment in disuse partly remains elusive.•The Raman spectroscopy is applied to characterize the molecular changes in the skeletal muscle of hindlimb unloaded mice.•The conformational changes and the breakdown of the molecular bonds in the skeletal muscle dictates loss of muscle mass.•The therapeutic drugs targeting specific molecules can be designed by identifying the changes in the skeletal muscles.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2405-5808
2405-5808
DOI:10.1016/j.bbrep.2021.100930